Metabolomic signatures associated with disease severity in multiple sclerosis

OBJECTIVE: To identify differences in the metabolomic profile in the serum of patients with multiple sclerosis (MS) compared to controls and to identify biomarkers of disease severity. METHODS: We studied 2 cohorts of patients with MS: a retrospective longitudinal cohort of 238 patients and 74 contr...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neurol Neuroimmunol Neuroinflamm
Asıl Yazarlar: Villoslada, Pablo, Alonso, Cristina, Agirrezabal, Ion, Kotelnikova, Ekaterina, Zubizarreta, Irati, Pulido-Valdeolivas, Irene, Saiz, Albert, Comabella, Manuel, Montalban, Xavier, Villar, Luisa, Alvarez-Cermeño, Jose Carlos, Fernández, Oscar, Alvarez-Lafuente, Roberto, Arroyo, Rafael, Castro, Azucena
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Lippincott Williams & Wilkins 2017
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5278923/
https://ncbi.nlm.nih.gov/pubmed/28180139
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000321
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller